Porphyrin-xylan-coated silica nanoparticles for anticancer photodynamic therapy.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Jun 2019
Historique:
received: 04 12 2018
revised: 14 02 2019
accepted: 19 02 2019
entrez: 19 3 2019
pubmed: 19 3 2019
medline: 19 7 2019
Statut: ppublish

Résumé

Porphyrins are widely used in anticancer photodynamic therapy (PDT). However, low physiological solubility and lack of selectivity towards cancer cells are the main limitations of their clinical use. Nanoparticles are being intensively explored as photosensitizer carriers for PDT to overcome these limitations. The aims of this work are to synthesize core-shell hybrid nanoparticles formed by a silica core and xylan carrying a 5-(4-hydroxyphenyl)-10,15,20-triphenylporphyrin (TPPOH) shell, and evaluate their anticancer activity. To afford drug-controlled incorporation and enhance blood circulation, TPPOH was covalently linked to xylan. Different xylans with degrees of substitution in TPPOH ranging from 0.034 to 1.11, were obtained and characterized. Then, the xylan-TPPOH conjugate (PX) was used to coat the silica nanoparticles (PX SNPs). The obtained nano-objects were characterized and their therapeutic potential for photodynamic therapy evaluated against colorectal cancer cell lines. in vitro analysis showed that PX SNPs were 40-fold and 10-fold more effective against HCT116 cells and HT-29 cells respectively compared to free TPPOH.

Identifiants

pubmed: 30879656
pii: S0144-8617(19)30212-7
doi: 10.1016/j.carbpol.2019.02.070
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Drug Carriers 0
Photosensitizing Agents 0
Porphyrins 0
Xylans 0
Silicon Dioxide 7631-86-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-175

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Soukaina Bouramtane (S)

Université de Limoges, Laboratoire PEIRENE, EA 7500, Faculté des Sciences et Techniques, 123 Avenue Albert Thomas, 87060 Limoges, France.

Ludovic Bretin (L)

Université de Limoges, Laboratoire PEIRENE EA 7500, Faculté de Pharmacie, 2, rue du Docteur Marcland, 87025 Limoges, France.

Aline Pinon (A)

Université de Limoges, Laboratoire PEIRENE EA 7500, Faculté de Pharmacie, 2, rue du Docteur Marcland, 87025 Limoges, France.

David Leger (D)

Université de Limoges, Laboratoire PEIRENE EA 7500, Faculté de Pharmacie, 2, rue du Docteur Marcland, 87025 Limoges, France.

Bertrand Liagre (B)

Université de Limoges, Laboratoire PEIRENE EA 7500, Faculté de Pharmacie, 2, rue du Docteur Marcland, 87025 Limoges, France.

Laurence Richard (L)

Centre Hospitalier Universitaire de Limoges, Service d'Anatomie Pathologique - 2, avenue Martin Luther King, 87042 Limoges cedex, France.

Frédérique Brégier (F)

Université de Limoges, Laboratoire PEIRENE, EA 7500, Faculté des Sciences et Techniques, 123 Avenue Albert Thomas, 87060 Limoges, France.

Vincent Sol (V)

Université de Limoges, Laboratoire PEIRENE, EA 7500, Faculté des Sciences et Techniques, 123 Avenue Albert Thomas, 87060 Limoges, France.

Vincent Chaleix (V)

Université de Limoges, Laboratoire PEIRENE, EA 7500, Faculté des Sciences et Techniques, 123 Avenue Albert Thomas, 87060 Limoges, France. Electronic address: vincent.chaleix@unilim.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH